In conclusion, the results of this study showed that while NPAA, platelet derived VEGF and TSP-1 levels were higher in NSCLC patients before surgery than in healthy controls, only both NPAA and platelet derived VEGF levels showed a statistically significant difference between the two groups. The gene discussed is THBS1; the disease is non-small cell lung carcinoma.